+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Infectious Disease Epidemiology, Vaccines and Immunology · Registering as Listener

ICIDEVI
📅 8 – 9 Apr 2027 📍 Copenhagen, Denmark 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Infectious Disease Epidemiology, Vaccines and Immunology
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 8 SDG 9

This track focuses on advanced methodologies in modeling the spread of infectious diseases. Participants will explore quantitative approaches to predict outbreaks and assess intervention strategies.

This session highlights recent advancements in vaccine technology and development processes. Discussions will include novel platforms, adjuvants, and the role of genomics in vaccine design.

This track examines the immune mechanisms triggered by vaccines and their implications for public health. Researchers will present findings on antibody responses, T-cell activation, and long-term immunity.

This session addresses the importance of surveillance systems in tracking infectious diseases. Participants will discuss innovative technologies and methodologies for effective disease monitoring.

This track focuses on the application of genomic sequencing in understanding pathogen evolution and transmission dynamics. Insights into real-time tracking of infectious agents will be shared.

This session will explore the effectiveness of various public health interventions in controlling infectious disease outbreaks. Case studies and policy implications will be discussed to inform future strategies.

This track emphasizes the importance of clinical trials in developing new treatments and vaccines for infectious diseases. Researchers will present their findings on trial design, outcomes, and ethical considerations.

This session will review methodologies for assessing vaccine efficacy and safety post-licensure. Participants will discuss real-world data and surveillance systems that monitor vaccine performance.

This track addresses the rise of emerging infectious diseases and the global response to these threats. Experts will discuss risk factors, outbreak preparedness, and innovative solutions.

This session highlights the importance of international partnerships in combating infectious diseases. Collaborative research efforts and data sharing initiatives will be explored.

This track examines how infectious diseases affect social and economic structures. Discussions will focus on the intersection of health, economics, and policy in managing disease outbreaks.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED